Atai Life Sciences Stock Cash Per Share
| ATAI Stock | USD 1.39 0.04 2.96% |
ATAI Life Sciences fundamentals help investors to digest information that contributes to ATAI Life's financial success or failures. It also enables traders to predict the movement of ATAI Stock. The fundamental analysis module provides a way to measure ATAI Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ATAI Life stock.
ATAI |
ATAI Life Sciences Company Cash Per Share Analysis
ATAI Life's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current ATAI Life Cash Per Share | 1.83 X |
Most of ATAI Life's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ATAI Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
In accordance with the recently published financial statements, ATAI Life Sciences has a Cash Per Share of 1.83 times. This is 57.93% lower than that of the Biotechnology sector and 57.74% lower than that of the Health Care industry. The cash per share for all United States stocks is 63.47% higher than that of the company.
ATAI Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ATAI Life's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ATAI Life could also be used in its relative valuation, which is a method of valuing ATAI Life by comparing valuation metrics of similar companies.ATAI Life is currently under evaluation in cash per share category among its peers.
ATAI Fundamentals
| Return On Equity | -0.83 | ||||
| Return On Asset | -0.28 | ||||
| Current Valuation | 224.27 M | ||||
| Shares Outstanding | 193.99 M | ||||
| Shares Owned By Insiders | 8.46 % | ||||
| Shares Owned By Institutions | 29.20 % | ||||
| Number Of Shares Shorted | 11.16 M | ||||
| Price To Earning | 0.30 X | ||||
| Price To Book | 2.25 X | ||||
| Price To Sales | 850.29 X | ||||
| Revenue | 308 K | ||||
| Gross Profit | 308 K | ||||
| EBITDA | (102.69 M) | ||||
| Net Income | (150.05 M) | ||||
| Cash And Equivalents | 304.06 M | ||||
| Cash Per Share | 1.83 X | ||||
| Total Debt | 7.58 M | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 12.25 X | ||||
| Book Value Per Share | 0.72 X | ||||
| Cash Flow From Operations | (82.44 M) | ||||
| Short Ratio | 2.38 X | ||||
| Earnings Per Share | (0.93) X | ||||
| Target Price | 8.0 | ||||
| Number Of Employees | 83 | ||||
| Beta | 1.19 | ||||
| Market Capitalization | 261.89 M | ||||
| Total Asset | 159.39 M | ||||
| Retained Earnings | (700.21 M) | ||||
| Working Capital | 55.17 M | ||||
| Current Asset | 320.15 M | ||||
| Current Liabilities | 74.35 M | ||||
| Net Asset | 159.39 M |
About ATAI Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ATAI Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ATAI Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ATAI Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether ATAI Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ATAI Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atai Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atai Life Sciences Stock:Check out ATAI Life Piotroski F Score and ATAI Life Altman Z Score analysis. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATAI Life. If investors know ATAI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATAI Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ATAI Life Sciences is measured differently than its book value, which is the value of ATAI that is recorded on the company's balance sheet. Investors also form their own opinion of ATAI Life's value that differs from its market value or its book value, called intrinsic value, which is ATAI Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATAI Life's market value can be influenced by many factors that don't directly affect ATAI Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATAI Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ATAI Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATAI Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.